PHAXIAM Therapeutics : monthly information related to total number of voting rights and shares composing the share capital – November 29, 2024
Rhea-AI Summary
PHAXIAM Therapeutics has released its monthly report on voting rights and share capital composition for November 29, 2024. The company's total shares remained stable at 10,013,719 since October 2024. The gross voting rights slightly increased to 10,166,025, while net voting rights stood at 10,165,776.
Notable changes occurred in July 2024 when the total shares increased from 6,075,105 to 9,980,668, representing a significant expansion in the company's share capital. The report includes monthly data from December 2023 through November 2024, tracking both gross and net voting rights in accordance with French Autorité des Marchés Financiers regulations.
Positive
- Significant share capital expansion from 6.07M to ~10.01M shares in July 2024
- Stable share count maintained since October 2024
- Slight increase in voting rights indicating potential institutional interest
Negative
- None.
Article 223-16 of general regulation of French Autorité des Marchés Financiers
Listing market: Euronext Paris (Market segment C - ISIN Code: FR001400K4B1- Symbol: PHXM)
Website : www.phaxiam.com
| Date | Total of shares composing the share capital | Total of brut (1) voting rights | Total of net (2) voting rights |
| December 31, 2023 | 6 075 105 | 6 226 982 | 6 226 733 |
| January 31, 2024 | 6 075 105 | 6 227 002 | 6 226 753 |
| February 29, 2024 | 6 075 105 | 6 226 951 | 6 226 702 |
| March 29, 2024 | 6 075 105 | 6 226 938 | 6 226 689 |
| April 30, 2024 | 6 075 105 | 6 226 932 | 6 226 683 |
| May 31, 2024 | 6 075 105 | 6 226 989 | 6 226 740 |
| July 1, 2024 | 9 980 668 | 10 132 597 | 10 132 348 |
| October 8, 2024 | 10 013 719 | 10 165 848 | 10 165 599 |
| October 31, 2024 | 10 013 719 | 10 165 846 | 10 165 597 |
| November 29, 2024 | 10 013 719 | 10 166 025 | 10 165 776 |
(1) Gross voting rights number (or « theoretical » voting rights) is used as a basis for calculating the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.
(2) Without treasury shares.
Attachment
FAQ
What is PHXM's current total number of shares as of November 29, 2024?
How many voting rights does PHXM have as of November 2024?
When did PHXM experience its most significant share capital increase in 2024?
